H pylori articles & resources on Made-in-China.com

Eisai Has Filed an Application for The Proton Pump Inhibitor Pariet in Japan

Dec 4, 2013

Eisai has filed an application for the proton pump inhibitor Pariet in Japan looking for a further indication expansion for use in the prevention of recurrent gastric or duodenal ulcer caused by low-dose aspirin therapy as well as the ...

Tags: Health, Medicine

US Patent and Trademark Office Has Granted Exalenz Bioscience The First Patent

Aug 22, 2013

The US Patent and Trademark Office has granted Exalenz Bioscience the first patent for its BreathID Platform technology's method of evaluating the liver condition of a patient. By computing and comparing breath test parameters, before and ...

Tags: US Patent, patients'liver condition

Pylori Gastritis Using Triple Therapy with Proton Pump Inhibitor

Feb 25, 2013

Takeda Pharmaceutical Company has announced the approval of Helicobacter pylori Gastritis as an additional indication to eradicate Helicobacter pylori using triple therapy with proton pump inhibitor by Japan's Ministry of Health, Labour and ...

Tags: Helicobacter pylori Gastritis, Helicobacter pylori eradication

Infection Is The Cause of Most Stomach and Duodenal Ulcers But Can Be Simply Cured

Dec 20, 2012

Infection with Helicobacter pylori is the cause of most stomach and duodenal ulcers but can be simply cured by a course of antibiotics. Easy detection is therefore clinically important. Traditional non-invasive tests for diagnosis of H. ...

Tags: Helicobacter pylori, antibiotics, Antigen test

New Therapy to Eradicate H. Pylori Be Launched by Pernix

Nov 28, 2012

Pernix Therapeutics Holdings has launched Omeclamox-Pak, a ten-day therapy, to eradicate Helicobacter pylori (H. pylori) in adult patients. Omeclamox-Pak is composed of omeprazole delayed-release capsules (20mg), clarithromycin tablets ...

Tags: Omeclamox-Pak, H.pylori, ten-day therapy

Pernix Presentations Triple Combination Oral Therapy to Treat H. Pylori Infection

Nov 28, 2012

Pernix Therapeutics, a specialty pharmaceutical company, has announced the availability of Omeclamox-Pak to treat Helicobacter pylori (H. pylori) infection and duodenal ulcer disease (active or one-year history) to eradicate H. pylori in ...

Tags: Oral Therapy, Omeclamox-Pak, H.pylori